Coverage at a glance
| Indication | Coverage |
|---|---|
| Type 2 diabetes | Covered with prior authorization |
Plan type: Commercial non-Medicare. Each indication below lists the BMI and clinical thresholds, the prior-authorization documentation, and the published policy it comes from.
Coverage by indication
What the prior authorization needs:
- A documented diagnosis of type 2 diabetes mellitus (ICD-10 E11) is the only approval criterion in the policy.
- Members with a claim for one non-GLP-1 anti-diabetes drug (for example metformin, an SGLT2 inhibitor, or insulin) in the previous 720 days receive automatic approval at the pharmacy with no prior authorization.
- The policy sets no A1C threshold and no mandatory prior-drug failure requirement for approval.
- Approvals last up to 12 months.
- Not approved for a sole diagnosis of obesity. The tirzepatide product for weight loss is Zepbound, covered under a separate anti-obesity policy.
Policy J-1300. Source: Pharmacy Policy Bulletin J-1300: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) for Diabetes - Commercial and Healthcare Reform. payer_policy. Verified August 27, 2026.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- If the prior-authorization request is denied, the appeal letter library has templates by denial reason, covering peer-to-peer review, Level 1 and Level 2 internal appeal, and external review.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time. Some participants get a placebo, decided at random.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Highmark cover Mounjaro?
Highmark covers Mounjaro (tirzepatide) for type 2 diabetes on its commercial and ACA (Healthcare Reform) plans under pharmacy policy J-1300. The only stated approval criterion is a documented type 2 diabetes diagnosis (ICD-10 E11), and members who already have a claim for another diabetes drug in the past 720 days are auto-approved at the pharmacy with no prior authorization. Highmark does not cover Mounjaro for weight loss and will not approve it for a sole diagnosis of obesity. Zepbound is the tirzepatide product FDA-approved for weight loss, and it sits under a separate Highmark anti-obesity policy. This reflects the published policy verified August 2026.
What does Highmark require to approve Mounjaro?
For type 2 diabetes: Prior authorization is required, with the documentation listed in the requirements above.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources; those rows are marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit. Those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
